Trademark: 97175024
Status Date
Thursday, January 25, 2024
Filing Date
Thursday, December 16, 2021
Published for Opposition
Tuesday, November 8, 2022
5 Injectable pharmaceutical preparations by prescription and over-the-counter, for use in connection with the treatment of oncological, dermatological, neurological, osteopathic, cardiovascular, respiratory, gastro-intestinal, and psychiatric disorders and viral and infectious diseases, bone disease, migraines, hormonal disorders, and hypertension; injectable pharmaceutical preparations, namely, anti-emetics, antibiotics, sedatives, neuromuscular blocking agents, anticonvulsant and muscle relaxants, and diagnostic preparations for medical purposes
Jan 26, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 25, 2024
Sou Extension 2 Granted
Dec 27, 2023
Sou Extension 2 Filed
Dec 27, 2023
Sou Teas Extension Received
Jul 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 11, 2023
Sou Extension 1 Granted
Jul 3, 2023
Sou Extension 1 Filed
Jul 11, 2023
Case Assigned To Intent To Use Paralegal
Jul 3, 2023
Sou Teas Extension Received
Jan 3, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 8, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 8, 2022
Published For Opposition
Oct 19, 2022
Notification Of Notice Of Publication E-Mailed
Oct 3, 2022
Approved For Pub - Principal Register
Oct 3, 2022
Examiner's Amendment Entered
Oct 3, 2022
Notification Of Examiners Amendment E-Mailed
Oct 3, 2022
Examiners Amendment E-Mailed
Oct 3, 2022
Examiners Amendment -Written
Sep 29, 2022
Notification Of Non-Final Action E-Mailed
Sep 29, 2022
Non-Final Action E-Mailed
Sep 29, 2022
Non-Final Action Written
Sep 22, 2022
Assigned To Examiner
Jan 4, 2022
Preliminary/Voluntary Amendment - Entered
Jan 4, 2022
Assigned To Lie
Dec 30, 2021
Teas Voluntary Amendment Received
Dec 21, 2021
New Application Office Supplied Data Entered
Dec 20, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
